CClinicalTrials.gg
RecruitingNCT06476171Updated Nov 25, 2024

Validation of Hematological Indices

An interventional study of Determination of the level of the studied biomarkers in Multiple Organ Dysfunction, Sepsis and Pneumonia, sponsored by Petrovsky National Research Centre of Surgery. Recruiting at 1 site in Russian Federation. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-11-25.

Sponsored by Petrovsky National Research Centre of Surgery · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Primary completion was expected by Nov 2025, 11 months ago, but the record still lists the study as recruiting.
  • Registered 8 months after the study started (first participant enrolled Jun 2023, registered Mar 2024).
  • Started Jun 2023; still recruiting 3 years 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Non-randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The hypothesis of the study is that hematological indices (neutrophil to lymphocyte ratio, platelet to lymphocyte ratio and systemic index of inflammation) may be predictors of infectious complications and multiple organ dysfunction in patients after cardiac surgery.

Read the detailed description

The hematological index validation study is a single-center interventional prospective study. The aim of the study: to determine the average and threshold values of hematological indices in patients with cardiac surgery before surgery and in the early postoperative period; to determine the levels of hematological indices that indicate an unfavorable course of the postoperative period and may be predictors of infection or multiple organ dysfunction. The study will include 200 patients who are shown cardiac surgery. Blood samples will be collected before the study at three stages: before the operation, on the first day after the operation and on the third day after the operation. Based on the hematological indices studied (NLR, PLR, SII), other biomarkers often used in clinical practice (presepsin, procalcitonin, interleukins, etc.) will also be determined. Each patient will be monitored throughout the perioperative period until the patient is discharged from the hospital by the study participants, in the future all records from the medical history will also be analyzed., including data from instrumental and laboratory studies, consultations of specialists. Based on these data, patients will be divided into groups depending on the presence of complications and their nature. Data concerning demographic indicators, the levels of biomarkers studied and the course of postoperative will be stored in the Exel program. Statistical analysis is planned to be carried out in the IBM SPSS Statistics program. For each quantitative indicator, the nature of the distribution will be determined using the Kolmogorov-Smirnov criterion. All quantitative data with a normal distribution will be presented in the form of mean and standard deviation; with a distribution other than normal - in the form of a median (Q2) and an interquartile span (Q1; Q3). Parametric and nonparametric criteria will be used to assess the differences between the samples, depending on the nature of the distribution. It is planned to complete the correlation analysis performed; assessment of the influence of independent variables on dependent, encoded binary, using logistic regression; construction of ROC curves. It is planned to calculate the odds ratio (OR), 95% confidence interval (CI) and the significance of the influence of p. In all cases, the results of statistical analysis are considered significant at p \< 0.05.

02

Conditions studied

  • Multiple Organ Dysfunction
  • Sepsis
  • Pneumonia
  • Wound Infection

Browse trials for

Keywords

  • Multiple Organ Dysfunction
  • Sepsis
  • cardiac surgery
  • hematological indices
03

In context

Wound Infection

382 studies on the registry are indexed under Wound Infection; 40 are open to participants now.

This study's planned enrollment of 200 is above the median of 150 across 296 interventional studies indexed under Wound Infection.

Browse Wound Infection studies →

Lead sponsor

Petrovsky National Research Centre of Surgery is the lead sponsor of 18 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • age from 18 to 80 years
  • cardiac surgery
  • operation in the conditions of cardiopulmonary bypass
  • availability of voluntary informed consent of the patient to participate in the study

Exclusion criteria

Exclusion Criteria:

  • refusal of the patient from the study
  • transfer of the patient to another medical institution
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Control Group

    A group of patients whose postoperative period proceeded without complications, in connection with which they were transferred to the specialized department within 1-2 days.

    Diagnostic Test: Determination of the level of the studied biomarkers

  • Experimental
    Group of patients with complications

    Patients who had postoperative complications: pneumonia, wound infection, sepsis, multiple organ dysfunction.

    Diagnostic Test: Determination of the level of the studied biomarkers

Interventions

  • Diagnostic testDetermination of the level of the studied biomarkers

    Determination of the level of hematological indices based on a general blood test; Determination of the levels of the following biomarkers: isolation of neutrophils from the blood using the gradient centrifugation method; assessment using enzyme immunoassay (ELISA) of the content of neutrophil elastase in the supernatant; myeloperoxidase, ELISA; lactoferrin, ELISA; interleukin -1ß,17,10,6, ELISA; presepsin, ELISA; endothelin, ELISA; lipopolysaccharide, LAL test; lipopolysaccharide binding protein, ELISA; NETs release, immunofluorescence method; the number of neutrophils expressing PDL-1, flow cytofluorimetry method; procalcitonin in human plasma and serum, VIDAS B.R.A.H.M.S. PCT; ferritin, reagent for determination (FERRITIN); lactate dehydrogenase, reagent for determination of QSR6128;Endotoxin Activity Assay, chemiluminescent immunodiagnostics.

06

What researchers measure

Primary outcomes

  1. Number of patients with onset of complications of any type in the postoperative period

    Recording by the attending physician of the occurrence of a complication

    Time frame: Up to 12 weeks

Secondary outcomes

  1. Changes in the levels of other biomarkers often used in clinical practice

    neutrophil elastase; myeloperoxidase; lactoferrin; interleukins -1β,17,10,6; presepsin; endothelin; lipopolysaccharide; lipopolysaccharide binding protein; procalcitonin; lactoferrin; interleukins -1β,17,10,6; presepsin; endothelin; lipopolysaccharide; lipopolysaccharide binding protein; procalcitonin; ferritin ; lactate dehydrogenase, tumor necrosis factor - alpha; Endotoxin Activity Assay

    Time frame: Up to 1 week

  2. Number of patients with nosocomial pneumonia

    In accordance with national clinical guidelines, the diagnosis of pneumonia was made with the appearance of fresh focal infiltrative changes in the lungs according to X-ray examination data in combination with two or more clinical and laboratory signs (acute fever 38,0 ° C and higher; cough with sputum; physical signs - focus of crepitation/small bubbly wheezing, bronchial respiration, shortening of percussion sound; leukocytosis \> 10 x 109 /l and/or rod shift \> 10%).

    Time frame: Up to 12 weeks

  3. Number of patients with wound infection

    The diagnosis of wound infection is established jointly with surgeons on the basis of examination of the postoperative wound during dressing and bacteriological examination of the discharge from the wound.

    Time frame: Up to 12 weeks

  4. Number of patients with multiple organ dysfunction

    With the dysfunction of two or more functional systems (cardiovascular, respiratory, renal-hepatic), the syndrome of multiple organ dysfunction was established

    Time frame: Up to 12 weeks

  5. Number of patients with sepsis

    If there is a focus of infection or suspected infection in combination with multiple organ dysfunction (+ 2 points on the SOFA scale), sepsis is diagnosed.

    Time frame: Up to 12 weeks

07

Study locations

1 of 1 sites recruiting
  • Petrovsky National Reasearch Centre of Surgery
    Moscow, 119991, Russian Federation
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 25, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06476171
Lead sponsor
Petrovsky National Research Centre of Surgery
Responsible party
Sponsor
First posted
Jun 26, 2024
Start date
Jun 19, 2023
Primary completion
Nov 1, 2025 (estimated)
Completion
Dec 30, 2025 (estimated)
Last update
Nov 25, 2024

Study contacts

Maxim A. Babaev, D.M.
Contact
maxbabaev@mail.ru
89160269066
Oxana O. Grin
Contact
grin_oksana@mail.ru
89168748565
Maxim A. Babaev, D.M.
principal investigator · Petrovsky NRCS

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion